Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1?year: Results from the CLEAR study

Blauvelt A.Reich K.TSEN-FANG TSAITyring S.Vanaclocha F.Kingo K.Ziv M.Pinter A.Vender R.Hugot S.You R.Milutinovic M.Tha?i D.2020-10-222020-10-2220170190-9622https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994735189&doi=10.1016%2fj.jaad.2016.08.008&partnerID=40&md5=55fc1502d00551e0aa6a8ac16f1bae43https://scholars.lib.ntu.edu.tw/handle/123456789/517589[SDGs]SDG3Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1?year: Results from the CLEAR studyjournal article10.1016/j.jaad.2016.08.008276630792-s2.0-84994735189